Gilead Sciences Inc buy BMO Capital Markets
Start price
20.10.25
/
50%
€105.20
Target price
20.10.26
€115.78
Performance (%)
14.21%
Price
10.04.26
€118.54
Summary
This prediction is currently active. The prediction currently has a performance of 14.21%. Dividends of €1.61 are taken into consideration when calculating the performance. This prediction currently runs until 20.10.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Gilead Sciences Inc | -2.162% | -2.162% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by BMO_Capital_Markets for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at BMO Capital Markets from $130.00 to $135.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€113.00
26.01.26
26.01.26
€126.35
26.01.27
26.01.27
5.63%
10.04.26
10.04.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€100.00
12.02.25
12.02.25
€110.81
12.02.26
12.02.26
28.16%
13.02.26
13.02.26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€89.58
07.11.24
07.11.24
€94.44
07.11.25
07.11.25
15.85%
08.11.25
08.11.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€80.64
17.10.24
17.10.24
€86.86
17.10.25
17.10.25
30.46%
18.10.25
18.10.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€73.00
16.05.23
16.05.23
€91.88
16.05.24
16.05.24
-14.51%
17.05.24
17.05.24

